Bridget O’Keeffe

Bridget O’Keeffe

Company: OncoSec Medical

Job title: Vice President, Clinical Development


A Novel Platform for Localized Intratumoral Expression Of Immunotherapy: GET IT 10:30 am

See why gene electrotransfer immunotherapy is a new platform with potential for tumor-localized expression of cytokines and low toxicity Understand how cytokines are a promising adjuvant to checkpoint inhibition Reveal how plasmid IL-12 (TAVO) has demonstrated activity in advanced melanoma and TNBCRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.